OMNIPAQUE 350 Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Omnipaque 350, and when can generic versions of Omnipaque 350 launch?
Omnipaque 350 is a drug marketed by Ge Healthcare and is included in two NDAs.
The generic ingredient in OMNIPAQUE 350 is iohexol. There are three drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the iohexol profile page.
Summary for OMNIPAQUE 350
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 98 |
Clinical Trials: | 25 |
Patent Applications: | 3,514 |
Formulation / Manufacturing: | see details |
DailyMed Link: | OMNIPAQUE 350 at DailyMed |
Recent Clinical Trials for OMNIPAQUE 350
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Fédération des médecins résidents du Québec | Phase 4 |
Centre for Interdisciplinary Research in Rehabilitation of Greater Montreal | Phase 4 |
Claire Bourgeois | Phase 4 |
Pharmacology for OMNIPAQUE 350
Drug Class | Radiographic Contrast Agent |
Mechanism of Action | X-Ray Contrast Activity |
Anatomical Therapeutic Chemical (ATC) Classes for OMNIPAQUE 350
US Patents and Regulatory Information for OMNIPAQUE 350
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ge Healthcare | OMNIPAQUE 350 | iohexol | SOLUTION;INJECTION, ORAL | 018956-004 | Dec 26, 1985 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Ge Healthcare | OMNIPAQUE 350 | iohexol | SOLUTION;INJECTION, ORAL | 020608-003 | Oct 24, 1995 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for OMNIPAQUE 350
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Ge Healthcare | OMNIPAQUE 350 | iohexol | SOLUTION;INJECTION, ORAL | 018956-004 | Dec 26, 1985 | ⤷ Try a Trial | ⤷ Try a Trial |
Ge Healthcare | OMNIPAQUE 350 | iohexol | SOLUTION;INJECTION, ORAL | 018956-004 | Dec 26, 1985 | ⤷ Try a Trial | ⤷ Try a Trial |
Ge Healthcare | OMNIPAQUE 350 | iohexol | SOLUTION;INJECTION, ORAL | 018956-004 | Dec 26, 1985 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for OMNIPAQUE 350
See the table below for patents covering OMNIPAQUE 350 around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Australia | 4861579 | ⤷ Try a Trial | |
Netherlands | 7905166 | ⤷ Try a Trial | |
Belgium | 855580 | ⤷ Try a Trial | |
Norway | 129093 | ⤷ Try a Trial | |
Japan | S5321137 | XXRAY CONTRAST MEDIUM | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |